INTRODUCTION
Prior studies have shown that antiserum raised to the Escherichia coli J5 vaccine binds to three bacterial outer membrane proteins (OMPs) that are present on serum-exposed smooth Enterobacteriaceae and in LPS-containing fragments that are released by bacteria incubated in human serum. The present studies were performed to further analyze release of the three OMPs into human serum. Normal human serum was incubated with E. coli O18K + bacteria and then filtered to remove intact bacteria. Lipopolysaccharide (LPS) was affinity-purified from sterile filtrates using murine monoclonal IgG directed against the O-polysaccharide chain of E. coli O18 LPS (monoclonal anti-O IgG). Components of sterile filtrates were also separated by ultracentrifugation on sequential potassium bromide and cesium chloride gradients. Samples were analyzed by immunoblotting, using anti-J5 IgG and polyclonal anti-O IgG as primary antibodies. Three OMPs, of MWs 5-9, 18, and 35 kDa were detected in samples that were affinity-purified using monoclonal anti-O IgG, indicating that complexes containing at least these three OMPs and LPS (OMP/LPS complexes) are released into human serum. The 18 kDa OMP was detected in low density fractions of the density gradients, indicating that this OMP is also released separately from the OMP/LPS complexes in a form that floats at the same density as serum lipoproteins.
(J5 antiserum) and the O-polysaccharide of E. coli O18 LPS (polyclonal anti-O) were prepared as previously described. 3, 4 IgG in J5 antiserum (anti-J5 IgG) does not cross-react with proteins in human serum by immunoblotting. The E. coli O18 O-polysaccharide vaccine consists of the O-polysaccharide conjugated to Pseudomonas aeruginosa toxin A (gift of A. Cross). 5 Monoclonal IgG to the O-polysaccharide of E. coli O18 LPS (monoclonal anti-O IgG) was produced by a mouse hybridoma (gift of A. Cross). 6 Rabbit polyclonal anti-O and mouse monoclonal anti-O IgGs do not cross-react with bacterial OMPs or human serum proteins by immunoblotting. IgG was purified by protein G affinity purification. 7 Murine monoclonal anti-O IgG and an unrelated murine monoclonal IgG 1 were covalently conjugated to magnetic beads as previously described. 4 
Affinity purification of bacterial components released into human serum
Bacteria were grown to mid-log phase, washed, suspended in normal human serum, and incubated for 2 h at 37°C. Bacteria were separated from the serum by filtration (0.2 µm), and LPS was affinity-purified from the sterile filtrates using monoclonal anti-O IgG coupled to magnetic beads. Antigen was eluted from the beads and then tested for LPS and the OMPs by immunoblotting with polyclonal anti-O IgG and anti-J5 IgG.
Lipoprotein preparation from filtrates of bacteria incubated in human serum
The lipoprotein fraction was prepared from sterile filtrates of serum incubated with bacteria by isopycnic density equilibrium ultracentrifugation. 8 Filtrates were first ultracentrifuged on a potassium bromide (KBr) gradient at a mean density of 1.2 g/cm 3 . Material in the topthird was washed once through a second KBr gradient (density of 1.2 g/cm 3 ). The top-third of the sample from the second KBr density gradient was then buffer exchanged and centrifuged on a cesium chloride (CsCl) density gradient (density of 1.15 g/cm 3 ). Fractions at different densities were studied by immunoblotting with anti-J5 IgG.
RESULTS

Fragments containing OMPs and LPS are released into human serum and are affinity-purified by anti-O IgG
LPS was affinity-purified from sterile filtrates of human serum incubated with bacteria using monoclonal anti-O IgG conjugated to magnetic beads, and bound antigens were eluted from the beads and analyzed by immunoblotting. Anti-J5 IgG stained three prominent bands of MWs 35, 18, and 5-9 kDa (Fig. 1) . The characteristic train-track pattern of LPS staining was present in samples stained with polyclonal anti-O IgG. The data indicate that a portion of LPS and the three OMPs are released into human serum as OMP/LPS complexes. These results are consistent with prior studies indicating that anti-LPS IgG affinity purifies LPS and bacterial outer membrane protein A from filtrates of serum-exposed Salmonella abortus equi bacteria. 9 The 18 kDa OMP is released into human serum in a low-density form Because LPS interacts with serum lipoproteins, we hypothesized that OMPs might associate with serum lipoproteins. 8, 10 Lipoproteins were prepared from sterile filtrates of normal human serum incubated with bacteria by isopycnic density equilibrium on KBr and CsCl gradients. All three OMPs and LPS were detected in the high-density section of the first KBr gradient. The 18 kDa OMP was also present in the low density fraction in the top-third of the first and second KBr gradients. The (lanes 1 and 3) . Unrelated mouse IgG1 was used as the negative control (lanes 2 and 4) . Material eluted from beads was electrophoresed on a 16% SDS-polyacrylamide gel, transferred electrophoretically to nitrocellulose, and developed with IgG in J5 antiserum (lanes 1 and 2) and polyclonal anti-O IgG (lanes 3 and 4) .
top third of the second KBr gradient was ultracentrifuged on the more refined CsCl gradient and analyzed by immunoblotting. The 18 kDa OMP, but not the 35 or 5-9 kDa OMPs, was detected in the low density fractions of the CsCl gradient, with a peak in fractions 6 and 7, at a density of 1.14-1.17 g/cm 3 (Fig. 2) . The 18 kDa OMP was not detected in filtrates of serum prepared in an identical fashion without the bacteria.
DISCUSSION
These studies indicate that E. coli O18:K1:H7 bacteria incubated in human serum release complexes containing LPS and at least three OMPs. These OMPs are bound by IgG in the protective antiserum raised to heat-killed E. coli J5 bacteria. Although anti-J5 IgG has been hypothesized to protect via anti-LPS IgG, there has not been conclusive evidence supporting this theory. 11 Human lipoproteins such as HDL are known to bind and detoxify LPS. Our data indicate that at least one OMP, of MW 18 kDa, is released into serum separately from the OMP/LPS complexes and floats in the same density range as human HDL when ultracentrifuged on gradients. Further studies will need to be done to determine whether the 18 kDa OMP specifically interacts with serum lipoproteins.
Our data raise the possibility that a portion of the protection conferred by J5 antiserum might result from anti-OMP antibodies and raise the question as to whether these non-LPS bacterial components may also play a role in the pathogenesis of Gram-negative sepsis. Fig. 2 . Immunoblot analysis and specific gravity of cesium chloride (CsCl) density gradient fractions. Normal human serum was incubated with E. coli O18:K1:H7 and filtered (0.1 µm). Sterile filtrates were diluted 5-fold into potassium bromide (KBr) at a calculated specific gravity of 1.22 g/cm 3 , and ultracentrifuged to generate a density gradient. The upperthird of the fraction was washed through a second KBr gradient. The upper-third from the second KBr gradient was then buffer exchanged and ultracentrifuged on a CsCl gradient at a calculated mean specific gravity of 1.15 g/cm 3 . Fractions of the cesium chloride gradient were immunoblotted using IgG from J5 antiserum, and specific gravity was determined by measurement of refractive indexes.
